X0206 3 2023-08-10 0 0001826667 TriSalus Life Sciences, Inc. TLSI 0001983649 Katz Steven C 6272 W. 91ST AVENUE WESTMINSTER CO 80031 0 1 0 0 Chief Medical Officer Common Stock 34443 D Employee Stock Option (right to buy) 3.64 2026-05-16 Common Stock 593 D Employee Stock Option (right to buy) 3.64 2027-01-17 Common Stock 2471 D Employee Stock Option (right to buy) 1.22 2028-04-17 Common Stock 2471 D Employee Stock Option (right to buy) 1.22 2029-01-21 Common Stock 2471 D Employee Stock Option (right to buy) 0.41 2030-10-05 Common Stock 115682 D Employee Stock Option (right to buy) 2.43 2031-11-02 Common Stock 32677 D Employee Stock Option (right to buy) 2.43 2032-04-19 Common Stock 90222 D Employee Stock Option (right to buy) 10.30 2033-05-18 Common Stock 31040 D The securities reported herein were acquired by the Reporting Person prior to the Reporting Person becoming an executive officer of the Issuer. The Reporting Person was appointed as an executive officer of the Issuer effective immediately after the effective time of the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.). Includes 16,644 shares issued pursuant to a restricted stock unit award ("RSU"). The RSU vests in four equal annual installments commencing on October 5, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. The shares subject to this stock option became fully vested on May 17, 2017. The shares subject to this stock option became fully vested on January 18, 2019. The shares subject to this stock option became fully vested on April 18, 2019. The shares subject to this stock option became fully vested on January 22, 2023. Twenty-five percent of the shares subject to the option vested on September 21, 2021, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Twenty-five percent of the shares subject to the option vested on November 3, 2022, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. 1/12th of the shares subject to this stock option vest on May 20, 2025, the first monthly anniversary following the third anniversary of the vesting commencement date with the remainder vesting in 11 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. Twenty-five percent of the shares subject to the option vest on May 19, 2024, the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. /s/ Sean Murphy, Attorney-in-Fact for Steven Katz 2023-08-14